1st human studies promising for Ebola vaccine designed at Canada's national lab

April 2, 2015 2:09 PM

15 0

TORONTO - The first human trials of a designed-in-Canada Ebola vaccine suggest it is safe and triggers a rapid immune response, two articles published Wednesday reveal.

The work, based on six clinical trials in the United States, Switzerland, Germany, Gabon and Kenya, found the vaccine quickly generates antibodies in people who receive it. Whether those antibodies protect against infection remains to be seen, but early evidence suggests that is a strong possibility...

Read more

To category page